Strides Shasun is currently trading at Rs. 1137.75, up by 11.15 points or 0.99% from its previous closing of Rs. 1126.60 on the BSE.
The scrip opened at Rs. 1132.25 and has touched a high and low of Rs. 1140.00 and Rs. 1129.00 respectively. So far 2185 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1412.45 on 23-Nov-2015 and a 52 week low of Rs. 848.00 on 29-Feb-2016.
Last one week high and low of the scrip stood at Rs. 1166.05 and Rs. 1095.00 respectively. The current market cap of the company is Rs. 10067.97 crore.
The promoters holding in the company stood at 31.14%, while Institutions and Non-Institutions held 46.98% and 21.88% respectively.
Strides Shasun has concluded the acquisition of controlling stake in Universal Corporation, Kenya. The company had earlier in February 08, 2016 inked definitive agreements to acquire a controlling stake in Universal Corporation, Kenya.
With this acquisition, the company will get a strong presence in the key east African markets and will complement its current capacities of six strategically located plants across major geographies in Sub Saharan Africa.
Strides Shasun (formerly known as Strides Arcolab) is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
